Form D · Other Health Care
Elira, Inc.
Ballwin, MO · CIK 0001652804
Offering snapshot reported Jun 7, 2024 · SEC filing
- Reported sold
- $3.43M Offering amount: $4.73M
- Investors reported
- 34 Form D · investor count
- Minimum accepted
- $400 Reported outside-investor minimum
- First sale
- Sep 13, 2023 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$2,052,815 → $3,429,720
- Reported investors22 → 34
- Minimum accepted$500 → $400
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 7, 2024 | Amendment | $3,429,720 | $1,376,905vs Sep 28, 2023 | 34 | SEC filing |
| Sep 28, 2023 | Initial | $2,052,815 | No comparison | 22 | SEC filing |
| Dec 27, 2022 | Initial | $1,252,844 | No comparison | 19 | SEC filing |
| Jan 12, 2021 | Initial | $1,574,312 | No comparison | 24 | SEC filing |
| Nov 14, 2019 | Initial | $973,729 | No comparison | 20 | SEC filing |
| Mar 14, 2019 | Initial | $912,662 | No comparison | 38 | SEC filing |
| Aug 20, 2018 | Initial | $923,093 | No comparison | 25 | SEC filing |
| Dec 29, 2017 | Initial | $1,924,701 | No comparison | 33 | SEC filing |
| Dec 6, 2016 | Initial | $1,901,254 | No comparison | 21 | SEC filing |
| Sep 14, 2015 | Initial | $1,096,250 | No comparison | 22 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-493333
Source: Form D, filed Jun 7, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| C. David Adair | Director |
| Charlie Bolten | Director |
| Charles Bolten | Director |
| Ralph G. Dacey | Director |
| Ralph G. Dacey, Jr. | Director |
| Jason A. Darrah | Executive |
| Steven A. Edmundowicz | Executive |
| Paul V. Goode | Director |
| Danika R. Harrison | Director |
| Bevil J. Hogg | Director |
| Derek H. Lee | Director |
| Luis J. Malave | Executive |
| Bankim H Mehta | Director, Executive |
| Arda M. Minocherhomjee | Director |
| Raul E. Perez | Director, Executive |
| A. Travis Spitzer | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
13610 Barrett Office Drive Suite 114
Ballwin, MO, 63021
Ballwin, MO, 63021